About Aether Capital
Overview
Aether Capital is an entity registered in Australia, founded on 28 October 2021. Its official domain is aethercapitals.com. The firm lists a registered address in London at Heron Tower, 13/F, 110 Bishopsgate, EC2N 4AD. As of the time of this review, no regulatory licenses or authorizations have been identified for this broker. This absence of regulation is a critical factor for potential clients to consider.
Company Details
The broker’s registration in Australia suggests it may be subject to Australian corporate laws, but without a financial services license from the Australian Securities and Investments Commission (ASIC), it does not hold the typical regulatory status expected for a forex or CFD broker. The London address is notable, as the United Kingdom’s Financial Conduct Authority (FCA) imposes strict requirements on financial firms operating there. However, Aether Capital does not appear on the FCA register. This discrepancy raises questions about the firm's actual operational oversight.
Regulatory Status
The FXCanary Scam Risk Score for Aether Capital is 75 out of 100, indicating a severe level of risk. This score is primarily driven by the complete absence of recognized regulatory oversight. Traders are advised that unregulated brokers do not offer the same protections as regulated entities, such as negative balance protection or access to compensation schemes. The lack of a verifiable regulatory status makes it difficult to assess the broker’s adherence to industry standards.
Conclusion
In summary, Aether Capital presents as an unregistered financial services provider with a high-risk profile. The combination of its Australian incorporation, London address, and non-existent regulatory footprint suggests that traders should proceed with extreme caution, if at all. Until independent verification of its operations and regulatory compliance becomes available, the broker should be considered high-risk.
Overview compiled by FXCanary from regulatory records and public data. full Aether Capital review